Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Kollodis BioSciences, Inc. logo — company profile

Kollodis BioSciences, Inc.

1 employees Biotechnology, Health Care

General Information

Company Name Kollodis BioSciences, Inc.
Employees 1
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Kollodis BioSciences, Inc.. To contact Kollodis BioSciences, Inc., visit kollodis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Kollodis BioSciences, Inc.

Kollodis BioSciences, Inc. is a biotechnology company specializing in bioadhesives and recombinant extracellular matrix (ECM) proteins for cell culture and related applications. The company offers a range of mussel adhesive protein (MAP) products, including stand-alone adhesives, adhesive kits, and specialized products for cell culture and tissue engineering. Its flagship product, the MAPTrix™ ECM line, comprises coating reagents with genetically incorporated bioactive peptides that mimic the activity of ECM proteins such as collagen, fibronectin, and laminin. These bioactive peptides facilitate cell attachment, spreading, and growth, while the mussel adhesive protein provides biocompatible adhesion to various surfaces. Additionally, the company offers the MAPTrix™ core product, recombinant mussel adhesive protein, and the MAPTrix HyGel™ line of chemically defined hydrogel products for 3D cell culture. Kollodis BioSciences, Inc. operates within the biotechnology and healthcare industries, positioning itself at the intersection of innovation and medical advancement. Through its unique product line, the company addresses the critical need for advanced cell culture and tissue engineering solutions, catering to the growing demand from biotech and healthcare professionals. However, key information such as the company's founding date, headquarters, and recent investments remains undisclosed, making it challenging to evaluate its current standing in the market. Investors seeking opportunities in the biotech and healthcare sectors may find Kollodis BioSciences, Inc. intriguing due to its focus on developing novel bioadhesives and ECM proteins. The company's innovative approach to cell culture and tissue engineering presents potential for market disruption and future growth. While additional details about recent investments and notable investors are unavailable at this time, Kollodis BioSciences, Inc. warrants further consideration for its unique product offerings and potential impact on the biotechnology landscape.

No funding data available for Kollodis BioSciences, Inc. yet.

FAQ About Kollodis BioSciences, Inc.

Bioadhesives & recombinant ECM proteins for cell culture & related applications: Kollodis BioSciences provides mussel adhesive protein (MAP) products as stand-alone adhesives (bioadhesives), ready-to-use adhesive kits, and specialized adhesives and products for cell culture, tissue engineering, a...
Kollodis BioSciences, Inc. operates in Biotechnology and Health Care.
Kollodis BioSciences, Inc. has approximately 1 employees.

We're actively collecting intelligence on Kollodis BioSciences, Inc..

Source: BounceWatch company record for Kollodis BioSciences, Inc., https://bouncewatch.com/company/kollodis-biosciences-inc, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes